PharmiWeb

ImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken Institute and Richard Nixon Foundation "Cancer 2035: A Roadmap for the Future" Summit

Dr. Soon-Shiong joins Nobel laureates, former NIH directors, and leading oncology pioneers in Washington, D.C. to chart a ...
PharmiWeb

Dental 3D Printing Market | Key Drivers, Emerging Challenges, and Strategic Insights, 2030

The dental 3D printing market is witnessing substantial growth, with an estimated compound annual growth rate (CAGR) of ...
PharmiWeb

AOP Health on Rare Diseases: Information. Collaboration. Innovation.

Why closing knowledge gaps matters for patients, healthcare and innovation.VIENNA--(BUSINESS WIRE)--#AOPHealth--Between 27 ...
PharmiWeb

Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer

Median progression-free survival (mPFS) was 15.1 months, and the confirmed overall response rate (cORR) increased to 45% for the 100mg QD (once daily) tablet cohort in an updated analysis of the ...
PharmiWeb

Rosen Law Firm Urges Corcept Therapeutics Incorporated (NASDAQ: CORT) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 ...
PharmiWeb

NHI Announces Appointment of Lilly H. Donohue to the Board of Directors

MURFREESBORO, TN / ACCESS Newswire / February 23, 2026 / National Health Investors, Inc. (NYSE:NHI) announced today that Lilly H. Donohue has been appointed to the NHI Board of Directors effective ...
PharmiWeb

Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide an overview of Puma at ...
PharmiWeb

Avant Brands Announces Timing of Release of Fiscal 2025 Annual Results

KELOWNA, BC / ACCESS Newswire / February 23, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products ...
PharmiWeb

QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS

First clinical development program in sporadic ALS patients to show potential to restore STATHMIN-2 expression, a statistically significant effect on a neurofilament biomarker, and an overall trend of ...
PharmiWeb

Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C

Accepted for priority review with Prescription Drug User Fee Act (PDUFA) action date of August 17, 2026--If approved, ...
PharmiWeb

Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors

Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin succeeds Srinivas Akkaraju, M.D., Ph.D., ...
PharmiWeb

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areasMISSISSAUGA, ...